What monozygotic twins discordant for phenotype illustrate about mechanisms influencing genetic forms of neurodegeneration
Ketelaar ME, Hofstra RMW, Hayden MR. What monozygotic twins discordant for phenotype illustrate about mechanisms influencing genetic forms of neurodegeneration. As monozygotic (MZ) twins are believed to be genetically identical, discordance for disease phenotype between MZ twins has been used in gen...
Saved in:
Published in | Clinical genetics Vol. 81; no. 4; pp. 325 - 333 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.04.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Ketelaar ME, Hofstra RMW, Hayden MR. What monozygotic twins discordant for phenotype illustrate about mechanisms influencing genetic forms of neurodegeneration.
As monozygotic (MZ) twins are believed to be genetically identical, discordance for disease phenotype between MZ twins has been used in genetic research to understand the contribution of genetic vs environmental factors in disease development. However, recent studies show that MZ twins can differ both genetically and epigenetically. Screening MZ twins for genetic and/or epigenetic differences could be a useful and novel approach to identify modifying factors influencing phenotypic expression of disease. MZ twins that are phenotypically discordant for monogenic diseases are of special interest. Such occurrences have been described for Huntington's disease, spinocerebellar ataxias, as well as for familial forms of Alzheimer's disease. By comparing MZ twins that are phenotypically discordant, crucial factors influencing the phenotypic expression of the disease could be identified, which may be of relevance for understanding disease pathogenesis and variability in disease phenotype. Overall, understanding the crucial factors in development of a neurodegenerative disorder will have relevance for predictive testing, preventive treatment and could help to identify novel therapeutic targets. |
---|---|
Bibliography: | istex:5C833D48D8609F5EBFCD2AE28C065D871BC48848 ark:/67375/WNG-CW9KKVX4-K ArticleID:CGE1795 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Feature-3 ObjectType-Review-1 |
ISSN: | 0009-9163 1399-0004 |
DOI: | 10.1111/j.1399-0004.2011.01795.x |